Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tvardi Therapeutics (TVRD) Preferred Stock Liabilities: 2012-2013

Historic Preferred Stock Liabilities for Tvardi Therapeutics (TVRD) over the last 2 years, with Dec 2013 value amounting to $65.6 million.

  • Tvardi Therapeutics' Preferred Stock Liabilities was N/A to $65.6 million in Q4 2013 from the same period last year, while for Dec 2013 it was $65.6 million, marking a year-over-year change of. This contributed to the annual value of $65.6 million for FY2013, which is 12.07% up from last year.
  • Per Tvardi Therapeutics' latest filing, its Preferred Stock Liabilities stood at $65.6 million for FY2013, which was up 12.07% from $58.5 million recorded in FY2012.
  • Over the past 5 years, Tvardi Therapeutics' Preferred Stock Liabilities peaked at $65.6 million during FY2013, and registered a low of $58.5 million during FY2012.
  • Its 2-year average for Preferred Stock Liabilities is $62.1 million, with a median of $62.1 million in 2012.
  • Data for Tvardi Therapeutics' Preferred Stock Liabilities shows a peak YoY increased of 12.07% (in 2013) over the last 5 years.
  • Tvardi Therapeutics' Preferred Stock Liabilities (Yearly) stood at $58.5 million in 2012, then rose by 12.07% to $65.6 million in 2013.